Search

everythinglearnresearchcommunity

for

Search:↓

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Large prostates link to more hair loss.

Chemoprevention, using drugs like finasteride and dutasteride, can help prevent prostate cancer.

5-ARI therapy may help prevent prostate cancer progression.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

ASLNC168501 may help restore hair growth in androgenetic alopecia by improving hair follicle stem cell function.

H19 may help prevent hair loss by keeping hair cells young.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Male pattern baldness may predict prostate cancer risk.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

Early-stage skin cells help regenerate hair follicles, with proteins SDF1, MMP3, biglycan, and LTBP1 playing key roles.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Dutasteride may help prevent prostate cancer, but more research is needed.

Tiny particles from brain cells help hair grow by targeting a specific hair growth pathway.

LncRNA018392 helps goat skin cells grow by increasing CSF1R.

Hair repigmentation can indicate malignancy and should be investigated.

Finding a positive nonsentinel lymph node in melanoma patients indicates a worse prognosis.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

Peptide nanoparticles can effectively deliver CRISPR-Cas9 to target KRAS mutations in cancer.

Early baldness in men may indicate a higher risk of prostate cancer.

RNase L hinders hair growth by altering immune signals.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

The new method found new shared genetic areas linked to both Type 2 Diabetes and Prostate Cancer.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Androgen-driven traits don't predict prostate cancer recurrence.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.